Screening for Depression and Anxiety in a Fatigued 36-Year-Old Female
All patients presenting with fatigue should be routinely screened for depression and anxiety using validated screening tools such as the PHQ-9 and GAD-7, as these mental health conditions are common underlying causes of fatigue and require specific treatment approaches.
Initial Screening Process
Step 1: Two-Question Depression Screen
- Ask the two validated screening questions:
- "Over the past 2 weeks, have you felt down, depressed, or hopeless?"
- "Over the past 2 weeks, have you felt little interest or pleasure in doing things?"
- If either question is positive (score of 2 - occurring more than half the days), proceed to full screening 1
Step 2: Comprehensive Screening
- Administer the full PHQ-9 for depression screening 2
- Administer the GAD-7 for anxiety screening 2
- Use recommended clinical cutoffs:
Assessment Considerations for Fatigued Patients
Medical Evaluation
- Rule out medical causes of fatigue that may mimic or coexist with depression/anxiety:
- Thyroid disorders
- Anemia
- Sleep disorders
- Chronic pain conditions
- Medication side effects 1
Specific Assessment for Fatigue
- Fatigue is present in over 90% of patients with major depressive disorder 3
- Evaluate fatigue dimensions:
- Physical (lack of energy, exhaustion)
- Cognitive (difficulty concentrating)
- Emotional (decreased motivation) 3
Comorbidity Assessment
- Health anxiety is common in patients with chronic fatigue (42.2% in one study) 4
- High comorbidity exists between depression and anxiety in fatigued patients, with 61% of depressed patients also having at least one anxiety disorder 5
Management Algorithm Based on Screening Results
If Depression is Identified (PHQ-9 ≥8):
- Prioritize depression treatment first when both depression and anxiety are present 2, 1
- Treatment options based on severity:
If Anxiety is Identified (GAD-7 ≥5):
- Determine specific anxiety disorder (GAD, social anxiety, health anxiety)
- Treatment options:
For Fatigue Management:
- Address underlying depression/anxiety as primary approach
- Consider medications with dopaminergic/noradrenergic action if fatigue persists after depression treatment 3, 6
- Non-pharmacological interventions: structured physical activity, light therapy 3
Follow-Up and Monitoring
- Reassess at 4 and 8 weeks after initiating treatment 2, 1
- If little improvement after 8 weeks despite good adherence:
- Add psychological treatment to pharmacotherapy or vice versa
- Change medication
- Consider referral from group to individual therapy 1
Common Pitfalls to Avoid
- Failing to follow up on positive screening results with proper diagnosis and treatment 1
- Omitting the self-harm item from the PHQ-9, which artificially lowers scores 2
- Relying solely on symptom counts without considering functional impairment 2
- Overlooking medical causes of depressive symptoms and fatigue 1
- Assuming fatigue will resolve with standard antidepressant treatment - fatigue often persists as a residual symptom 6
By following this structured approach to screening and assessment, clinicians can effectively identify and manage depression and anxiety in fatigued patients, addressing both the mental health conditions and the fatigue symptoms.